Drugs
In a significant breakthrough in the treatment of ischemic heart disease, the combination of the antiplatelet monoclonal antibody drug ReoPro (abciximab) with stent placement has been shown to reduce the risk of death by 57 percent in patients with ischemic heart disease, compared to those undergoing stenting alone. The results,
Drugs
DuPont and Lynx Therapeutics have entered into a research collaboration to develop new crop varieties and crop protection products. The five-year collaboration, worth up to $60 million, will provide DuPont with exclusive access to Lynx's technologies for the study of corn, soybeans, wheat, and rice. This partnership aims
Drugs
Monsanto Co.'s announcement that it would stop enrolling patients in its test of the heart drug orbofiban, which prevents blood clots, sent the company's stock plummeting by 10.5 percent, losing $4.44 a share and closing at $38 a share. The decision came after an
Drugs
Hemispherx Biopharma has issued a statement in response to a press release by Asensio & Co., which allegedly misstated the content of a Food and Drug Administration (FDA) letter. According to Hemispherx, Asensio & Co. has been disseminating medical opinions on the efficacy and safety of Ampligen, which contradict the
Drugs
Hemispherx Biopharma, Inc., a pharmaceutical company, has found itself at the center of a controversy after issuing a press release on October 23, 1998, which failed to disclose critical information about a U.S. Food and Drug Administration (FDA) investigation. The press release, which announced the company's compliance
Drugs
Britain's top 100 executives collected a total of £160m in pay last year, a 45% increase from £110m the previous year, according to a Sunday Times analysis. JAN LESCHLY, chief executive of SmithKline Beecham, gained a 300% pay rise, making him the most "overpaid" executive for
Drugs
The unaudited results for SmithKline Beecham's nine months ended September 30, 1998 show significant changes in accounting policies and financial performance. The company adopted Financial Reporting Standard 10, "Goodwill and Intangible Assets," which reduced the amortization period for purchased goodwill from 40 years to 20 years.
Drugs
Barr Laboratories, Inc. has charged DuPont Pharmaceuticals with using scare tactics to protect a 40-year monopoly on the Coumadin anticoagulant. The accusation comes after DuPont's attempt to pressure the Virginia Board of Pharmacy into supporting their efforts to delay the generic erosion of their market share. Barr has
Drugs
Rhone-Poulenc S.A. and Hoechst AG, the two shareholders of Centeon, have reassessed their plasma proteins joint-venture following interactions with the US Food and Drug Administration (FDA). The facility in Kankakee, Illinois, was temporarily suspended due to a recent FDA inspection. Centeon plans to restart production in late October, focusing
Drugs
Vical Inc., a biopharmaceutical company focused on the development of gene-based pharmaceutical product candidates, has launched a corporate website to provide easy access to detailed information for its various constituencies. The website, vical.com, contains sections for investors, research scientists, clinical trial participants, potential employees, and business affiliates. The site
Drugs
Serono Laboratories, the world's leading producer of drug therapies for infertility, has launched a comprehensive website dedicated to providing information and support to patients and healthcare providers. The website, www.infertilityresource.com, aims to promote patient education and empowerment, and includes interactive patient education sections, treatment options, and
Drugs
A class action has been filed in the United States District Court for the District of New Jersey against Schein Pharmaceutical, Inc., alleging that the company made material misstatements and omissions in its Registration Statement and Prospectus regarding its failure to comply with current Good Manufacturing Practices (cGMP) at its
